Dublin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering.
This report contains a comprehensive listing of 658 diagnostic imaging deals announced since 2016, including financial terms where available, and links to online deal records of actual diagnostic imaging partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.
Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the diagnostic imaging deals entered into by the world's leading biopharma companies.
Fully revised and updated, the report provides details of diagnostic imaging deals from 2016 to 2025. The report provides a detailed understanding and analysis of how and why companies enter diagnostic imaging deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. The report includes collaboration, development, research and licensing deals.
The initial chapters of the report orient readers to diagnostic imaging dealmaking by covering the introduction, trends since 2016, leading deals by headline value, and the top 25 most active companies. Detailed reviews of deals and partnerships, focusing on specific technologies, are also discussed, complemented by a deal directory organized by company, deal type, and therapeutic target.
The report also includes numerous tables and figures that illustrate the trends and activities in diagnostic imaging dealmaking since 2016. In addition, a comprehensive deal directory is provided, organized by company A-Z, deal type, and therapeutic target. Each deal title links via Weblink to an online version of the deal record and, where available, the contract document, providing easy access to each contract document on demand.
Diagnostic Imaging Collaboration and Licensing Deals provides the reader with the following key benefits:
- Understand deal trends since 2016
- Browse diagnostic imaging collaboration and licensing deals
- Benchmark analysis - identify market value of transactions
- Financials terms - upfront, milestone, royalties
- Directory of deals by company A-Z, deal type and therapy area
- Leading deals by value
- Most active dealmakers
- Identify assets and deal terms for each transaction
- Access contract documents - insights into deal structures
- Due diligence - assess suitability of your proposed deal terms for partner companies
- Save hundreds of hours of research time
Analyzing contract agreements allows due diligence of:
- What are the precise rights granted or optioned?
- What is actually granted by the agreement to the partner company?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are IPRs handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes to be resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
Key Topics Covered:
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Trends in diagnostic imaging dealmaking
2.1. Introduction
2.2. Diagnostic imaging deals over the years
2.3. Most active diagnostic imaging dealmakers
2.4. Diagnostic imaging deals by deal type
2.5. Diagnostic imaging deals by therapy area
2.6. Diagnostic imaging deals by industry sector
2.7. Deal terms for diagnostic imaging deals
2.7.1 Diagnostic imaging deals headline values
2.7.2 Diagnostic imaging deal upfront payments
2.7.3 Diagnostic imaging deal milestone payments
2.7.4 Diagnostic imaging royalty rates
Chapter 3 - Leading diagnostic imaging deals
3.1. Introduction
3.2. Top diagnostic imaging deals by value
Chapter 4 - Most active diagnostic imaging dealmakers
4.1. Introduction
4.2. Most active diagnostic imaging dealmakers
4.3. Most active diagnostic imaging deals company profiles
Chapter 5 - Diagnostic imaging contracts dealmaking directory
5.1. Introduction
5.2. Diagnostic imaging contracts dealmaking directory
Chapter 6 - Diagnostic imaging dealmaking by technology type
Deal directory
Deal directory - Diagnostic imaging deals by company A-Z
Deal directory - Diagnostic imaging deals by deal type
Deal directory - Diagnostic imaging deals by therapy area
Deal type definitions
Companies Featured
- 3M
- Abbott Laboratories
- Accuray
- AC Immune
- Actelion
- Agilent Technologies
- Albany Molecular Research
- Alnylam Pharmaceuticals
- Amag Pharmaceuticals
- American Health Imaging
- Antaros Medical
- APRINOIA Therapeutics
- Arup Laboratories
- Aspect Imaging
- Astellas Pharma
- Aslan Pharma
- AstraZeneca
- Bayer
- Beckman Coulter
- Bio-Techne
- Biogen
- Boston Scientific
- Canon
- Carestream Health
- Celgene
- Clovis Oncology
- Duke University
- Eli Lilly
- Emory University
- Fujifilm
- GE Healthcare
- Genentech
- Guardant Health
- Harvard University
- Hitachi
- IBM Watson Health
- iCAD
- Johnson & Johnson
- Massachusetts General Hospital
- Medtronic
- Microsoft
- NVIDIA
- Pfizer
- Philips
- Quest Diagnostics
- Roche
- Siemens Healthineers
- Sony
- Stanford University
- Thermo Fisher Scientific
- Yale University
For more information about this report visit https://www.researchandmarkets.com/r/kk3q87
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
